iRhythm Technologies, Inc. (IRTC) Insider Trading Activity

NASDAQ$112.88-6.69 (-5.60%)
Market Cap
$3.93B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
331 of 853
Rank in Industry
49 of 108

IRTC Insider Trading Activity

IRTC Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$56,892
1
3
Sells
$29,375,655
38
97

Related Transactions

TALWALKAR ABHIJIT Ydirector
1
$56,892
3
$2.33M
$-2.27M
Freeman Sean ClintonEVP, Strategy & Corp Devt
0
$0
1
$114,484
$-114,484
Lawrence Brian LeeChief Technology Officer
0
$0
1
$122,491
$-122,491
Rodda JulianneEVP, CHIEF PEOPLE OFFICER
0
$0
1
$257,919
$-257,919
Rosenbaum Marc WadeChief Accounting Officer
0
$0
3
$793,874
$-793,874
Smith MervinEVP Strategic Business Ops
0
$0
5
$1.19M
$-1.19M
Shrishrimal SumiEVP, Chief Risk Officer
0
$0
3
$1.88M
$-1.88M
Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
0
$0
4
$2.64M
$-2.64M
Wilson Daniel G.Chief Financial Officer
0
$0
4
$2.89M
$-2.89M
Murphy Patrick MichaelCBO and CLO
0
$0
4
$2.96M
$-2.96M
Patterson ChadCHIEF COMM & PRODUCT OFFICER
0
$0
5
$3.05M
$-3.05M
Blackford Quentin S.President and CEO
0
$0
4
$11.15M
$-11.15M

About iRhythm Technologies, Inc.

iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.

Insider Activity of iRhythm Technologies, Inc.

Over the last 12 months, insiders at iRhythm Technologies, Inc. have bought $56,892 and sold $29.38M worth of iRhythm Technologies, Inc. stock.

On average, over the past 5 years, insiders at iRhythm Technologies, Inc. have bought $394,099 and sold $13.81M worth of stock each year.

Highest buying activity among insiders over the last 12 months: TALWALKAR ABHIJIT Y (director) — $56,892.

The last purchase of 5,312 shares for transaction amount of $56,892 was made by TALWALKAR ABHIJIT Y (director) on 2026‑05‑11.

List of Insider Buy and Sell Transactions, iRhythm Technologies, Inc.

2026-09-02SaleWilson Daniel G.Chief Financial Officer
773
0.0023%
$121.83
$94,175
+0.14%
2026-08-10SaleBlackford Quentin S.President and CEO
26,859
0.0816%
$124.65
$3.35M
-1.84%
2026-08-10SaleMurphy Patrick MichaelCBO and CLO
7,093
0.0215%
$124.65
$884,156
-1.84%
2026-08-10SalePatterson ChadCHIEF COMM & PRODUCT OFFICER
7,093
0.0215%
$124.65
$884,170
-1.84%
2026-08-10SaleTurakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
7,093
0.0215%
$124.65
$884,151
-1.84%
2026-08-10SaleShrishrimal SumiEVP, Chief Risk Officer
5,372
0.0163%
$124.65
$669,641
-1.84%
2026-08-03SalePatterson ChadCHIEF COMM & PRODUCT OFFICER
2,712
0.0082%
$122.12
$331,192
-1.23%
2026-08-03SaleSmith MervinEVP Strategic Business Ops
617
0.0019%
$122.12
$75,349
-1.23%
2026-08-03SaleRodda JulianneEVP, CHIEF PEOPLE OFFICER
2,112
0.0064%
$122.12
$257,919
-1.23%
2026-07-02SaleTurakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
1,423
0.0043%
$124.71
$177,462
-3.64%
2026-07-02SaleFreeman Sean ClintonEVP, Strategy & Corp Devt
918
0.0028%
$124.71
$114,484
-3.64%
2026-05-11SaleTALWALKAR ABHIJIT Ydirector
5,312
0.0163%
$117.93
$626,430
+0.07%
2026-05-11PurchaseTALWALKAR ABHIJIT Ydirector
5,312
0.0015%
$10.71
$56,892
+0.07%
2026-05-04SaleLawrence Brian LeeChief Technology Officer
1,014
0.0031%
$120.80
$122,491
-1.76%
2026-03-16SaleSmith MervinEVP Strategic Business Ops
2,585
0.008%
$114.30
$295,466
+3.85%
2026-03-02SaleBlackford Quentin S.President and CEO
13,813
0.041%
$128.44
$1.77M
-7.94%
2026-03-02SaleMurphy Patrick MichaelCBO and CLO
4,357
0.0129%
$128.44
$559,624
-7.94%
2026-03-02SalePatterson ChadCHIEF COMM & PRODUCT OFFICER
4,444
0.0132%
$128.44
$570,804
-7.94%
2026-03-02SaleTurakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
4,027
0.012%
$128.45
$517,259
-7.94%
2026-03-02SaleShrishrimal SumiEVP, Chief Risk Officer
2,830
0.0084%
$128.44
$363,484
-7.94%
Total: 244
*Gray background shows transactions not older than one year

Insider Historical Profitability

29.79%
Blackford Quentin S.President and CEO
226008
0.6877%
$27.02M111
<0.0001%
Murphy Patrick MichaelCBO and CLO
69699
0.2121%
$8.33M012
Patterson ChadCHIEF COMM & PRODUCT OFFICER
62125
0.189%
$7.43M116
+7.62%
Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
60116
0.1829%
$7.19M010
Shrishrimal SumiEVP, Chief Risk Officer
44621
0.1358%
$5.34M010
Wilson Daniel G.Chief Financial Officer
34887
0.1062%
$4.17M023
TALWALKAR ABHIJIT Ydirector
25611
0.0779%
$3.06M24
+64.11%
Smith MervinEVP Strategic Business Ops
22410
0.0682%
$2.68M08
Lawrence Brian LeeChief Technology Officer
20154
0.0613%
$2.41M01
Rodda JulianneEVP, CHIEF PEOPLE OFFICER
18201
0.0554%
$2.18M01
Rosenbaum Marc WadeChief Accounting Officer
16706
0.0508%
$2M07
Freeman Sean ClintonEVP, Strategy & Corp Devt
13641
0.0415%
$1.63M01
Novo A/S10 percent owner
2124448
6.4647%
$254.02M10
+35.85%
SYNERGY LIFE SCIENCE PARTNERS L P10 percent owner
2034524
6.191%
$243.27M02
New Leaf Ventures II, L.P.10 percent owner
1741589
5.2996%
$208.24M10
+35.85%
King Kevin M
250422
0.762%
$29.94M021
Day Mark J.Chief Technology Officer
61164
0.1861%
$7.31M08
Devine DouglasChief Operating Officer
29566
0.09%
$3.54M08
Vort David AChief Commercial Officer
27952
0.0851%
$3.34M044
Sung DerrickEVP, Strat Corp Development
25258
0.0769%
$3.02M07
Bobzien BriceChief Financial Officer
24428
0.0743%
$2.92M03
Garrett Matthew C.Chief Financial Officer
20867
0.0635%
$2.5M09
Bairey Merz Cathleen Noeldirector
4887
0.0149%
$584,338.5904
SNYDERMAN RALPHdirector
4256
0.013%
$508,889.9202
Bodaken Bruce G.director
3606
0.011%
$431,169.4202
Scott Raymond W.director
1764
0.0054%
$210,921.4807
Lathi Vijay Kdirector
0
0%
$0116
+35.85%
*Gray background shows insiders who have made transactions during last year

IRTC Institutional Investors: Active Positions

Increased Positions159+40.15%5M+13.64%
Decreased Positions169-42.68%4M-12.11%
New Positions47New2MNew
Sold Out Positions45Sold Out705,578Sold Out
Total Postitions386-2.53%35M+1.53%

IRTC Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$567,730.0010.13%3.24M+4,439+0.14%2025-09-30
Blackrock, Inc.$503,841.008.99%2.88M+125,841+4.58%2025-09-30
Artisan Partners Limited Partnership$449,880.008.02%2.57M-173,328-6.32%2025-09-30
Sands Capital Management, Llc$391,811.006.99%2.24M-679,417-23.3%2025-09-30
Capital Research Global Investors$207,414.003.7%1.18M-323,128-21.44%2025-09-30
State Street Corp$148,565.002.65%847,878-20,647-2.38%2025-09-30
Geode Capital Management, Llc$138,442.002.47%790,104+22,768+2.97%2025-09-30
Blair William & Co/Il$129,789.002.32%740,721+1,390+0.19%2025-09-30
Eventide Asset Management, Llc$121,167.002.16%691,512-61<0.01%2025-09-30
Fmr Llc$109,354.001.95%624,095+203,894+48.52%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.